Challenges in Biopsy and Cytology for Upper Tract Urothelial Carcinoma

Overview

This global study assessed diagnostic ureteroscopy (dURS) biopsy techniques and urine cytology in upper tract urothelial carcinoma (UTUC). Findings reveal that biopsy quality is sufficient in most cases, but diagnostic yield and accuracy vary, with urine cytology showing limited predictive value. The study highlights variability in biopsy methods and the need for improved diagnostic strategies.

Background

Upper tract urothelial carcinoma (UTUC) treatment depends on accurate histologic confirmation and staging. Guidelines from the European Association of Urology (EAU) and American Urology Association (AUA) recommend risk stratification to guide treatment, with kidney-sparing surgery for low-risk and radical nephroureterectomy for high-risk disease. Diagnostic ureteroscopy (dURS) with biopsy and cytology plays a key role, but real-world data indicate inconsistent use and uncertain diagnostic accuracy. This study explores biopsy techniques, diagnostic yield, and the added value of cytology in UTUC.

Data Highlights

Key Findings

• 83.5% of biopsy samples were adequate for diagnosis, with no significant difference between biopsy techniques or ureteroscope types.
• Rigid forceps were more commonly used for ureter tumors, baskets for pyelocaliceal tumors, and larger tumors (>2 cm) were more often biopsied with baskets.
• Among adequate biopsies, 64.3% were low-grade and 23.4% were high-grade tumors.
• Tumor stage was reported in 62% of biopsies, predominantly Ta stage.
• Urine cytology showed a statistically significant but limited concordance with final surgical pathology grade.
• There was variability in biopsy use and technique across centers, reflecting real-world practice challenges.

Clinical Implications

Clinicians should recognize that while biopsy during dURS generally provides sufficient diagnostic material, variability in technique and tumor characteristics can affect yield and accuracy. Urine cytology alone has limited predictive value and should be interpreted alongside biopsy results. Standardization of biopsy procedures and reporting may improve diagnostic confidence and guide appropriate treatment selection in UTUC.

Conclusion

This global practice study underscores the challenges in biopsy and cytology for UTUC diagnosis, highlighting the need for standardized approaches to optimize diagnostic accuracy and patient stratification. Improved biopsy techniques and combined diagnostic modalities are essential for effective clinical decision-making.

References

1. EAU and AUA Guidelines on UTUC Risk Stratification
2. CROES-UTUC Registry Data and Analysis
3. ClinicalTrials.gov NCT02281188 -- CROES-UTUC Registry Protocol